| Dr Thomas Czeczok, | |
|
800 E Carpenter St, Springfield, IL 62769-0001 | |
| (217) 522-3117 | |
| Not Available |
| Full Name | Dr Thomas Czeczok |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 9 Years |
| Location | 800 E Carpenter St, Springfield, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316329857 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Johns Hospital | Springfield, IL | Hospital |
| St Marys Hospital | Decatur, IL | Hospital |
| St Anthonys Memorial Hospital | Effingham, IL | Hospital |
| St Francis Hospital | Litchfield, IL | Hospital |
| St Joseph's Hospital | Highland, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associated Pathologists Ltd | 0345212866 | 11 |
News Archive
The American Academy of Neurology has issued a new guideline on the most effective treatments for diabetic nerve pain, the burning or tingling pain in the hands and feet that affects millions of people with diabetes. The guideline is published in the April 11, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology, and will be presented April 11, 2011, at the American Academy of Neurology's Annual Meeting in Honolulu.
A new drug called avosentan significantly lowers urinary protein excretion-an important marker of kidney disease progression-in patients with diabetic kidney disease, according to an international clinical trial appearing in the March 2009 issue of the Journal of the American Society Nephrology (JASN).
A new UT Southwestern study shows how an effective but largely abandoned treatment for Type 2 diabetes could be used again in combination with another drug to eliminate problematic side effects.
Raptor Pharmaceutical Corp.,provides updates on timelines related to its clinical programs including the pivotal Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").
The Measles Initiative partners - led by the American Red Cross, U.S. Centers for Disease Control and Prevention, the United Nations Foundation, UNICEF and the World Health Organization - will announce the latest achievement in global health during a press teleconference on Thursday, December 4, 2008 at 10:00 a.m. EST, 4:00pm CET.
› Verified 7 days ago
| Entity Name | Associated Pathologists Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174564587 PECOS PAC ID: 0345212866 Enrollment ID: O20040806000244 |
News Archive
The American Academy of Neurology has issued a new guideline on the most effective treatments for diabetic nerve pain, the burning or tingling pain in the hands and feet that affects millions of people with diabetes. The guideline is published in the April 11, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology, and will be presented April 11, 2011, at the American Academy of Neurology's Annual Meeting in Honolulu.
A new drug called avosentan significantly lowers urinary protein excretion-an important marker of kidney disease progression-in patients with diabetic kidney disease, according to an international clinical trial appearing in the March 2009 issue of the Journal of the American Society Nephrology (JASN).
A new UT Southwestern study shows how an effective but largely abandoned treatment for Type 2 diabetes could be used again in combination with another drug to eliminate problematic side effects.
Raptor Pharmaceutical Corp.,provides updates on timelines related to its clinical programs including the pivotal Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").
The Measles Initiative partners - led by the American Red Cross, U.S. Centers for Disease Control and Prevention, the United Nations Foundation, UNICEF and the World Health Organization - will announce the latest achievement in global health during a press teleconference on Thursday, December 4, 2008 at 10:00 a.m. EST, 4:00pm CET.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Czeczok, 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 | Dr Thomas Czeczok, 800 E Carpenter St, Springfield, IL 62769-0001 Ph: (217) 522-3117 |
News Archive
The American Academy of Neurology has issued a new guideline on the most effective treatments for diabetic nerve pain, the burning or tingling pain in the hands and feet that affects millions of people with diabetes. The guideline is published in the April 11, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology, and will be presented April 11, 2011, at the American Academy of Neurology's Annual Meeting in Honolulu.
A new drug called avosentan significantly lowers urinary protein excretion-an important marker of kidney disease progression-in patients with diabetic kidney disease, according to an international clinical trial appearing in the March 2009 issue of the Journal of the American Society Nephrology (JASN).
A new UT Southwestern study shows how an effective but largely abandoned treatment for Type 2 diabetes could be used again in combination with another drug to eliminate problematic side effects.
Raptor Pharmaceutical Corp.,provides updates on timelines related to its clinical programs including the pivotal Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").
The Measles Initiative partners - led by the American Red Cross, U.S. Centers for Disease Control and Prevention, the United Nations Foundation, UNICEF and the World Health Organization - will announce the latest achievement in global health during a press teleconference on Thursday, December 4, 2008 at 10:00 a.m. EST, 4:00pm CET.
› Verified 7 days ago
Cassi Brielle Grotepas, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 800 E Carpenter St, Springfield, IL 62769 Phone: 217-522-3117 | |
Dr. Onsi W Kamel, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 800 E Carpenter St, Springfield, IL 62769 Phone: 217-544-6464 | |
Cody Eric Freitag, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 800 E Carpenter St, Springfield, IL 62769 Phone: 217-522-3117 | |
Joan Barenfanger, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 701 N 1st St, Memorial Medical Center Laboratory Medicine, Springfield, IL 62781 Phone: 217-788-3672 Fax: 217-788-5577 | |
Michael Jon Beckmann, DO Pathology Medicare: Not Enrolled in Medicare Practice Location: 701 N 1st St, Memorial Medical Center, Springfield, IL 62781 Phone: 217-788-3064 Fax: 217-788-5577 | |
Patrick R Hemmer, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 800 E Carpenter St, Springfield, IL 62769 Phone: 217-544-6464 |